Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04871451 · ClinicalTrials.gov registry record · Phase 2

Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia

A Phase 2 study of Cervical Dystonia, sponsored by AEON Biopharma.

Completed
Registry status
Phase 2
Development phase
51
Enrollment target
20
Study locations

NCT04871451 is a Phase 2 study of Cervical Dystonia that has completed, run by AEON Biopharma. The registered enrollment target is 51 participants, below the 84-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (39% lower). The trial reports 20 study locations across 11 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04871451, a Phase 2 study of Cervical Dystonia, has completed, sponsored by AEON Biopharma.

COMPLETED
Registry status
Phase 2
Development phase
51 participants
Enrollment target
20
Study locations

Study Summary

This Open-label Extension trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 42 sites in the United States from Phase 2 (ABP-19000) trial. Study subjects who had their initial dose of study drug in the Phase 2 trial, irrespective of treatment allocation, will be eligible to enroll in this OLE study.

Conditions Studied

Cervical Dystonia

Interventions

  • DRUG ABP-450

Study Locations (20)

Florida

  • Infinity Clinical Research LLC - Hollywood
  • Brainstorm Research - Miami
  • University of South Florida - Tampa
  • Neurology One - Winter Park

California

  • Parkinson's and Movement Disorder Institute - Fountain Valley
  • Neuro Pain Medical Center - Fresno
  • Loma Linda University - Loma Linda

Ohio

  • The Cleveland Clinic Foundation - Cleveland
  • Cleveland Clinic Lou Ruvo Center for Brain Health - Cleveland
  • The Orthopedic Foundation - New Albany

Michigan

  • Michigan State University - East Lansing
  • Quest Research Institute - Hunt - PPDS - Farmington Hills

Tennessee

  • Veracity Neuroscience LLC - Memphis
  • Vanderbilt University Medical Center - Nashville

Arizona

  • Arizona Neuroscience Research - Phoenix

Connecticut

  • New England Institute for Neurology and Headache - Stamford

Georgia

  • Emory University - Atlanta

Trial Details

FieldValue
Enrollment Target 51 participants
Start Date 2021-07-27
Est. Completion 2023-07-24
Phase Phase 2

Sponsor

AEON Biopharma

4 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04871451

The ClinicalTrials.gov registry entry for NCT04871451 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 84-participant average among 15 other Cervical Dystonia trials with a reported enrollment target (39% lower). The listed sponsor is AEON Biopharma, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cervical Dystonia appearing as the primary indexed condition, and to 1 intervention - of which ABP-450 is the first listed.

NCT04871451 reports 20 study locations spanning 11 distinct geographic areas - top geographies include Florida, California, Ohio.

Frequently Asked Questions

What is clinical trial NCT04871451 about?

NCT04871451 is a clinical study titled "Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia". This Open-label Extension trial will evaluate the safety and efficacy of ABP-450 for the treatment of cervical dystonia in adults. The study will enroll 60 patients across approximately 42 sites in the United States from Phase 2 (ABP-19000) trial. Study subjects who had their initial dose of study d...

What is the current status of trial NCT04871451?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 51 participants. The study started on 2021-07-27. Estimated completion is 2023-07-24.

What conditions does trial NCT04871451 study?

This clinical trial studies the following conditions: Cervical Dystonia.

What interventions are being tested in trial NCT04871451?

The interventions under investigation include: ABP-450 (DRUG).

Who is sponsoring clinical trial NCT04871451?

This trial is sponsored by AEON Biopharma, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04871451 being conducted?

This trial has 20 study locations across Arizona, California, Connecticut, Florida, Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cervical Dystonia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cervical Dystonia

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.